ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

A. Lindo Patterson: Pioneer and Mentor

October 26, 2021

ASCO Special Awards Honor Oncology Leaders.

April 2, 2010

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

FDA Employee Inspired to Compose an Anthem for the Agency.

August 4, 2006

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004